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Acrosin inhibitors of seminal vcsiclc origin. after binding to their acceptor molcculcs on the anterior part of ejaculated sperm. arc thought to be 
important capacitation factors, protecting zona binding sites during sperm utcrinc passage, and then dissociating to allow sperm binding to the 
zona pellucida of the oocytc. Each species so far tested possess an heterogeneous population of isoinhibitors which may display overlapping but 
not identical biological functions. Hcrc WC report tlic complete primary structure of three isoforms of a boar sperm-associated acrosin inhibitor, 
whose scqucnccs arc 90% identical to the seminal plasma counterpart. Despite this high analogy, the diffcrcnccs bctwccn the sperm-associatcrl and 
the suminal plusmu inhibitors muy confer to them different physico.chcmical propertics which arc pos~ulatd to be of functional importance. 
Boar acrosin isoinhibitor; Amino acid scqucncc; Mass spcftromutry 
I. INTRODUCTION 
Acrosin inhibitors are seminal vesicle secretory poly- 
peptides tructurally related to the serine proteinasc in- 
hibitors of the i&al-type [I], a large family of homolo- 
gous proteins ubiquitous in all vertebrate species o far 
investigated [2]. The biological role of acrosin inhibitors 
have not been rigidly defined, however. At ejaculation, 
sperm is mixed with, and binds to a number of seminal 
components from the secretions of the accessory sexual 
glands, including acrosin inhibitors. They may protect 
the male and/or female genital tract epithelia gainst he 
proteolytic degradation by acrosin liberated from occa- 
sional damaged spermatozoa [3,4]. Additionally, by 
binding to acceptor molecules on the sperm surface, 
they may play a role as capacitation factors stabilizing 
receptors necessary for the sperm-oocyte interaction, 
i.e. zona pellucida-binding sites, which may become x- 
posed after release of the inhibitor during sperm res- 
idence in the female tract [5,6]. Seminal plasma acrosin 
inhibitors of the Kazal-type have been isolated and se- 
quenced from boar [l], bull [7-91 and human [IO]. In the 
boar, as in other species, isoinhibitors, thought to be 
natural mutants and gene products of different genes, 
have been identified [l]. In this report we have isolated 
and sequenced three isoforms of a boar sperm-associ- 
ated acrosin inhibitor. The sequences of these isoforms 
differ only at their N- and C-terminal parts, and are 
90% identical to the known sequence of the boar semi- 
nal plasma acrosin inhibitor [I]. The differences be- 
tween the seminal plasma and the sperm-associated 
isoinhibitor forms show that they may be different gene 
products. Moreover, these structural differences may 
confer to both molecules different physico-chemical 
properties which, most probably, are of functional im- 
portance. A group of low molecular weight boar sperm 
proteins mediating the binding of the isoinhibitors to 
the sperm surface was also identilied. 
2. ANALYTICAL METHODS 
Correspmkrtce ddrax E. Tapfer-Pctcrsen, Dcrmatologischc Klinik, 
Department of Dermatology, Andrology Unit, University of Munich, 
FraucnlobstraDc 9/l I, W-5000 MUnchen 2. Germany. 
Spcrm.associated acrosin inhibitors were isolated and identified as 
in [I 11. Briefly, fresh ejaculated boar scmcn was scparatcd from scmi- 
nal plasma by ccntrifugation at GO0 x g for 20 min. Spermatozoa were 
resuspcndcd and washed twice by centrifugalion with SO mM N- 
morpholinocthane sulfonic acid, 0.264 M sucrose. pH 6.5. The fmal 
pellet was cxtractcd overnight at 4°C with one volume of 2.5% (v/v) 
acetic acid containing 10% (v/v) glycerol and 50 mM bcn~;lmidinc. 
Ah ccntrifugation at 14,000 x g for IO min at 4°C the clear super- 
natant was fractionated on a Sephsdcx G-50 column (3.9 x 78 cm) in 
I mM HCI. The fractions were ncutralhud with I M Tris. diluted I: I 
(v/v) with 50 mM Na,CO$NaHC03 pH 9.6, immobilitcd onto ELISA 
plates, and tested with an anti-boar seminal inhibitor pOlyClOndl anti- 
body 1121. In parallel, each fraclion was lcslcd for acrosin inhibitory 
activity as in [I 31. The positive kictions of both assays wore pooled, 
lyophilyrcd. dissolved in 5 mM ammonium acetate. pH G.0. and 
applied to a DE-Ccllulosc 52 column (2.5 x I4 cm) uquilibrdled with 
the same buffer. Aflcr washing, the retained material was clutcd with 
a 5-200 mM ammonium acciatc pradicnt at pH 6.0. The flow-through 
fractions, which contained acrosin inhibitor(s), wcrc conccntralcd and 
desalted by ultratiltration using an Amicon cell with a UM5 
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mcmbrunc. Further purilicution of xrosin inhibitors was performed 
by rcucrse-phase chromatography using it Vydac Cl8 RPC analytical 
column, equilibrated with ;I mixlurc ofO.18 (v/v) trifluoroacclic acid 
in wltcr (A) and 0. I% Wluoroxwic ncid in accloni\rilc (l3) and clutcd 
first isocratically (20% 13) for 5 min followed by a lincar grndient up 
to 35% B in 30 min, nt a Ilow rate of I mllmin. The fractions containing 
xrosin inhibitor(s). which elu~cd at 26% B. were lyophilizcd. 
N-terminal scqucncr analyses were done with an Applied Bio- 
systems gas-phase sequencer model 473.4. following the msnufx- 
turer’s inslructions. 
SDS-gel clcctrophoresis was done according to Luemmli [Id]. 
Reduction of cystinc residues was accomplished with 2.mcrcspto- 
ethanol (5% (U/Y), tillalconccntrution),nnd deriuatization ofthc newly 
exposed cyst&es was done wilh a Z-fold molar excess of +vinylpy- 
ridine over reducing agent. 
Fast bomb;lrdment mass spcclra wcrc rccordcd with a mass spcctro- 
mctcr MAT 900 (Finnigan MAT. Brcmen) equipped with a liquid 
secondary ion ionization system. Time-of-Right pl;tsma dcsorption 
mass speclrometry \vits done using ;I Bioion (Uppsalu, Swcdcn) spec- 
iromcter with a z5zCf ionization source. 
3. RESULTS AND DlSCUSSlON 
Clcavagc of the acrosin inhibitor (IO n@nl in 70% (v/v) formic acid) 
at muthionine rcsiducs was done with cyanogen bromide (100 mg/ml 
linal concentration) for 4 h al room tempcralurc in the dark. The 
reaction mixture was then dilulcd wilh water and lyophilyzed. 
Native or cyunogen bromide-treated acrosin inhibitor (5 tng/ml in 
50 mM ammonium bicarbonate ptl 8.0) was further degraded with 
chymotrypsin (Sigma) at an enzyme/substrate ratio of I:100 (w/w) 
ovcmight at 37°C. 
Isolation of pcptides was done by reverse-phase HPLC on n Li- 
chrosphcr RP-100 (Merck, Darmstadt) Cl8 column (25 x 0.4 cm, 5 
pm particle size) cluting ut I mllmin with a linear stepwise gradient 
of 0. I % TFA in (A) water and (l3) xetonitrile. 
Acrosin inllibitors tightly associated to washed boar 
spermatozoa were isolated following the procedure de- 
veloped by Jondkovti et al. [I I], as described above. The 
final HPLC-isolated product showed a single broad 
electrophoretic band of about 8 kDa. Molecular weight 
determination by time-of-flight mass spectrometry 
clearly showed the existence of two major components 
with a molecular weight average of 769 1 t:8 and 79243 
Da (Fig.. 1). N-terminal sequence analysis confirmed the 
presence of two polypeptides whose sequences were: 
4 iY3 
r 
Fig. I. Determination of the molcculnr weight of the ncrosin isoinhibitors. The molecular weight of the componcnis present in the sperm-associated 
acrosin isoinhibitor sample was mcusured by time-of-flight plasma desarption mass spectrometry using Wf-induced ionization. Species corre- 
sponding to the mono-, di- and tri-protonatcd (M’. M” and M3+, rcspcctivcly) qu~aimolccular ions were observed. The spectrum was recorded 
at an acceleration voltage of I7 kV and corresponded to the average of 20 x 10” primary ions. Inset: analysis of the HPLC-purified isoinhibitor 
fraction by SDS-polyacrylamide (15%) gel clectrophoresis; 31 the left. molecular wcighl markers in kDa. 
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ARSKKTRKEPDCDVYRSHLFFCTREMDICGTNG...,~~~ 
SKKTRKEPDCDWRSHLFFCTREMDICGTNGKS... 
This result indicated that the inhibitor fraction 
actually contained a mixture of two structurally related 
peptides which may differ solely in their N-terminal 
ends, since the mass difference between AKS and S (227 
Da) corre?ponds to the mass difference betweent he 
two major molecular ions identified by mass spec- 
trometry (Fig. 1). 
The complete amino acid sequence of the acrosin 
Isoinhibitors was obtained by N-terminal sequencing of 
the whole fraction and of a set of HPLC-purified cya- 
nogen bromide cleavage products and chymotryptic 
peptides derived from reduced and ethylpyridylated 
samples (Fig. 2). Sequence assignment was confirmed 
by fast atom bombardment mass spectrometiric analysis 
of chymotryptic peptides obtained from underivatized 
samples. In addition, three intramolecular disulphide 
bridges were identified (Fig. 2). The disulphide bridge 
pattern (Cl-C’, C”-C’, C3-C6) is typical for serine 
proteinase inhibitors of the Kazal-type [l]. 
Among the cyanogen bromide peptides charac- 
terized, a minor component was found whose amino 
acid sequence was: GHCREYTSAARS. Thus, beside 
the two major isoinhibitors a third minor component 
with an extended C-terminal end was present (Fig. 2). 
When the amino acid sequences of the sperm-associ- 
ated acrosin isoinhibitors were compared with all the 
protein sequences deposited in the MIPS data bank, 
1 IO 20 
only significant analogy with other Kazal-type serine 
proteinase inhibitors was found. The strongest analogy 
(90% amino acid sequence identity) was with the boar 
seminal plasma acrosin inhibitor [l]. Thus, their amino 
acid sequences only differ (Fig. 2) in that (a) the sperm- 
associated counterpart contains N-terminal extensions 
of 3 or 5 amino acids; (b) five positions showing glu- 
tamine or asparagine in the seminal plasma isoinhibitor 
contain the corresponding carboxylic acid in the sperm- 
associated isoform; (c) two adjacent residues have their 
relative positions changed; and (d) the minor com- 
ponent of the sperm-associated acrosin isoinhibitor 
possesses an extra alanine residue at its C-terminal end. 
These differences ( hown in boldface in Fig. 2) indicated 
that the sperm-associated and the seminal plasma 
acrosin isoinhibitors may be products of different genes. 
On the other hand, the three sperm-associated isoinhi- 
bitors may arise by alternative proteolytically process- 
ing of the same gene product. 
Despite the apparently small sequence differences, a
closer analysis indicated that the seminal plasma and 
the sperm-associated isoinhibitors may possess different 
physico-chemical properties. Thus, whereas the seminal 
plasma inhibitor is a glycoprotein [I], the isoinhibitors 
characterized here are not glycosylated. Furthermore, 
the sperm-associated forms possess isoelectric points of 
about one pH unit lower than that of the seminal 
plasma counterpart (8.2-8.4 vs. 9.5). Interestingly, all 
amide/carboxylic a id substitution, except he one ad- 
jacent to the active arginine residue (shown in shadow 
30 40 50 
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ARSKKTRKEPDCDVYRSHLFFCTlREMDPlCGTNGKSYANPClFCSEKLGRNEKFD 
S 
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Fig. 2. Alignment of the amino acid sequence of the seminal plasma nd the sperm-associated acrosin isoinhibitors. The seminal plasma acrosin 
inhibitor (upper sequence) isfrom [I]. The complete primary Wucture of the sperm-associated isoinhibitors (this work) was ob~ainecl by protein- 
chemical and mass spcctromclric analyses. The sequence isnumbered taking the longest form as reference. CB. cyanogcn bromide fragment; C. 
cbymotryptic derived peptidc. The numbers below a given fragment correspond to its molecular weight (Mel-i’) dctcrmincd by fast atom 
bombardment mass spectrometry. The differences between the seminal plasma [I] and the sperm-associated acrosin isoinhibitors are indicated in 
boldface. The active argine residue is shown in shadow. The C-lerminal extension found in a minor componcnl is in italics between brackets. S-S, 
disulphide bridge. 
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in Fig. 2), lie on the same face of the molecule, when the 
structure of the sperm-associated acrosin inhibitor was 
modelled with the known three-dimensional coor- 
dinates of its homologous elastase inhibitor (courtesy of 
Dr. W. Bode, Martinsried). These molecular features 
may be of functional significance regarding its binding 
to sperm acceptor molecules. In this respect it may be 
noticed that we have not found the seminal plasma 
inhibitor [1] in extracts of washed sperm. 
Experiments in our laboratory show that the acrosin 
isoinhibitors characterized here specifically recognize 
low molecular weight (14-I 8 kDa) boar sperm-associ- 
ated component(s), some of which have been implicated 
in the binding of the spermatozoon to its homologous 
egg’s zona pellucida [IS, IG] (data not shown). This in- 
teraction does not inhibit the subsequent binding of the 
sperm protein(s) to isolated zona pellucida. 
Mammalian sperm is mixed with, and binds to a 
number of seminal components at ejaculation. The sub- 
sequent removal of at least some of these components 
is a necessary feature of capacitation. In the mouse, a 
low molecular weight (6.4 kDa) acrosin inhibitor of 
seminal plasma origin binds at ejaculation to the sperm 
plasma membrane covering the apical portion of the 
acrosome [17]. The inhibitor interacts with a 15 kDa 
acceptor molecule [lg], and inhibits the binding of 
sperm to zona pellucida [19-211. The authors postulate 
that binding of the inhibitor to its acceptor molecule 
may stabilize specific sites necessary for sperm-egg in- 
teraction, and that during sperm residence in the female 
genital tract, the inhibitor is released from the sperm 
surface and the zona-binding sites are exposed. Our 
data agree with this hypothesis. Further studies are, 
however, needed to precisely identify the inhibitor-bind- 
ing boar sperm component(s), and its relationship to the 
mouse 15 kDa acceptor molecule. Since sperm-zona 
pellucida binding is mediated through a (sperm) pro- 
tein-(zona) carbohydrate recognition mechanism, it 
would be interesting to delineate the relationship be- 
tween the inhibitor binding site and the zona binding 
s!te within the sperm protein(s). Another exciting ques- 
t?on which remains to be solved is whether or not the 
inhibitor utilizes the protease-binding site for interac- 
tion with its sperm acceptor. 
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